Raven biosciences ApS: Financial statements 2020
CVR: 39085127
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Raven biosciences ApS (CVR 39085127) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 2,243,527 and a net result of DKK -255,472 compared with DKK 412,749 the year before. That is a decrease of 53.1% compared with the year before. The profit margin was -11.4%. Equity in the 2020 report amounted to DKK 413,041. The solvency ratio was 42.4%.
- Revenue
- DKK 2,243,527
- Gross Profit
- DKK 2,104,786
- Profit/Loss
- DKK -255,472
- Equity
- DKK 413,041
- Total Assets
- DKK 974,519
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 2.2 mio. | 2.1 mio. | -255 t. | 413 t. | - |
| 2019 | 4.8 mio. | 3.4 mio. | 413 t. | 669 t. | - |
Official annual report
How creditworthy is Raven biosciences ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Raven biosciences ApS has published its annual report for 2019. Revenue came to DKK 4,787,235, and the net result was DKK 412,749.
About Raven biosciences ApS
Raven biosciences ApS is a Danish company of the type Anpartsselskab based in Aarhus N, founded in 2017. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The management consists of Kenneth Graabek Johansen and Roald Forsberg. The company's owners include Kenneth Graabek Johansen, Roald Forsberg and KGJ Invest ApS. The company has 7 employees (2026). In 2025, the company reported revenue of DKK 6,977,057 and a net result of DKK 1,065,066 compared with DKK -925,200 the year before. Equity in the 2025 report amounted to DKK 2,861,815.